Please login to the form below

Not currently logged in
Email:
Password:

key opinion leaders

This page shows the latest key opinion leaders news and features for those working in and with pharma, biotech and healthcare.

GSK to reverse ‘no KOL’ policy, admitting it has hit marketing

GSK to reverse ‘no KOL’ policy, admitting it has hit marketing

Company seeking to revive lacklustre marketing performance. GlaxoSmithKline is to reverse its ban on paying healthcare professionals and key opinion leaders (KOLs), admitting that the policy has hit awareness of its ... Nevertheless, GSK will be keen to

Latest news

  • A unique ecosystem A unique ecosystem

    For Medicen, it is also very important to focus on its key strategic areas and provide access and platforms for showcasing the latest research results in the field of life science. ... Start-ups from either cluster could attend B2B meetings and

  • Harnessing the unrivalled power of key opinion leaders Harnessing the unrivalled power of key opinion leaders

    Harnessing the unrivalled power of key opinion leaders. The critical value of engaging KOLs early in the drug development process. ... Engaging early. Engaging the right key opinion leaders (KOLs) at an early stage in the life cycle, and utilising their

  • Spink wins gastroenterology society account Spink wins gastroenterology society account

    ESPGHAN’s annual congress is attended by over 4, 000 delegates and globally attracts key opinion leaders in the field of paediatric gastroenterology, hepatology and nutrition. ... Managing relations with the medical trade and global press, Spink will

  • Riding the wave of digital disruption Riding the wave of digital disruption

    And the key to thriving in this brave new world lies with the changing needs of the healthcare professional. ... Specifically, Gorini's team in Italy is working to use this customer data to tailor interactions with key opinion leaders to follow their

  • Connected Healthcare Connected Healthcare

    Despite the inexorable shift to digital, Cello's research has found that information received face-to-face from peers, key opinion leaders (KOLs), pharma sales representatives and sponsored conferences remain the

More from news
Approximately 0 fully matching, plus 97 partially matching documents found.

Latest Intelligence

  • Developing advocacy in the pharmaceutical industry Developing advocacy in the pharmaceutical industry

    In fact, having open and honest relationships with your key opinion leaders (KOLs) is crucial to launching and growing a successful brand and is an important element of any business plan. ... The development of a charter is an elegant way of doing this

  • The Patient Journey

    the audience, whether this be patients, healthcare professionals or key opinion leaders. ... 5 Engage with key influencers throughout the patients’journeys. This allows the development of a robust strategic patient pathway.

  • How Augmented reality is disrupting healthcare How Augmented reality is disrupting healthcare

    Combining situational and sensorial learning via AR is an exciting way to improve information retention, deepen understanding of benefits and even pre-market complicated products to key opinion leaders. ... Forward-thinking companies will lead the  way

  • Understanding HCPs to build a meaningful brand Understanding HCPs to build a meaningful brand

    2. Add value to HCP Digital Opinion Leaders. Pharmaceutical companies that develop relationships with highly engaged online HCPs are likely to achieve better reach and engagement overall online. ... Conversely, your existing Key Opinion Leaders (KOLs)

  • Accelerating diagnosis in rare disease Accelerating diagnosis in rare disease

    Companies can help raise disease awareness by engaging with key opinion leaders (KOLs) and driving impactful campaigns using a multichannel communication approach. ... Companies can support these by ensuring that content is memorable, engaging and leaves

More from intelligence
Approximately 3 fully matching, plus 31 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • How can pharma engage with key stakeholders on NHS service transformation?

    Industry should also refine its proposition for transformation leads, medicines management staff and other key opinion leaders (KOLs), who may have different drivers and priorities. ... Pharma can also take a lead in facilitating discussions between

  • Developing advocacy in the pharmaceutical industry.

    In fact, having open and honest relationships with your key opinion leaders (KOLs) is crucial to launching and growing a successful brand and is an important element of any business plan. ... The development of a charter is an elegant way of doing this

  • Scrip World Pharmaceutical News

    We filter the flood of information on the industry and apply the knowledge of our extensive network of analysts, journalists and key opinion leaders to provide our readers with timely

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Conversis

Conversis is a translation company specialising in translation and localisation for the Life Science and Pharmaceutical industry, with particular focus...

Latest intelligence

World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...

Infographics